TFX
TELEFLEX INC
NYSE · Healthcare · Medical - Instruments & Supplies · US
$124.52
−0.85%Next report
Analyst consensus
- Next report date
- Nov 5, 2026
- EPS estimate
- $1.92
- Revenue estimate
- $565.4M
Latest reported
- Last report date
- Aug 6, 2026
- EPS actual
- $1.76
- EPS estimate
- $1.28
- Revenue actual
- $570.3M
- Revenue estimate
- $559.6M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 10
- EPS misses (12Q)
- 1
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- -117.8%
- Revenue beats (12Q)
- 5
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $159
- PT range
- $145 – $170
- Analysts
- 6
3 Buy3 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 6, 2026 | $1.28 | $1.76 | Beat 37.50% | $570.3M |
| May 7, 2026 | $1.21 | $1.39 | Beat 14.88% | $548.3M |
| Feb 26, 2026 | $3.74 | -$16 | Miss -532.10% | -$401.9M |
| Nov 6, 2025 | $3.38 | $3.67 | Beat 8.45% | $913.0M |
| Jul 31, 2025 | $3.36 | $3.73 | Beat 10.95% | $780.9M |
| May 1, 2025 | $2.89 | $2.91 | Beat 0.73% | $700.7M |
| Feb 27, 2025 | $3.85 | $3.89 | Beat 1.04% | $795.4M |
| Oct 31, 2024 | $3.39 | $3.49 | Beat 3.04% | $764.4M |
| Aug 1, 2024 | $3.33 | $3.42 | Beat 2.58% | $749.7M |
| May 2, 2024 | $3.07 | $3.21 | Beat 4.46% | $737.8M |
| Feb 22, 2024 | $3.27 | $3.38 | Beat 3.43% | $773.9M |
| Nov 2, 2023 | $3.27 | $3.64 | Beat 11.31% | $746.4M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 5, 2026